11/11/2013

The future of biologics can be protected through 12-year data exclusivity under the Trans-Pacific Partnership, Colorado College's Kristina Lybecker writes. Intellectual property protections need to adapt to ensure that the development of biologics remains economically viable while safeguarding patients, she writes.

Full Story:
IPWatchdog.com

Related Summaries